default author photo

Karine Le Malicot

University of Franche-Comté

SCHOLARLY PAPERS

3

DOWNLOADS

178

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Pembrolizumab in Combination with CAPOX and Bevacizumab in Patients with Microsatellite Stable Metastatic Colorectal Cancer and a High Immune Infiltrate: Preliminary Results of the Single-Arm, Phase II, Open-Label FFCD 1703-POCHI Trial

Number of pages: 23 Posted: 09 Dec 2024
Université de Poitiers - Gastroenterology Department, Assistance Publique-Hôpitaux de Paris - Department of Pathology, Ambroise Paré, Saint-Malo Hospital Centre, University of Franche-Comté, Hôpital Saint Joseph, Centre François Baclesse, University of Limoges, Centre Hospitalier Général de Quimper, Hôpital Franco-Britannique, Perpignan Hospital Center, Infirmerie Protestante, Caluire et Cuire, Roche-Sur-Yon Hospital, Université de Rennes 1 - CHU de Rennes, Sainte Catherine Institute, Hôpital Franco-Britannique, University of Lorraine - Department of Hepatogastroenterology, University of Franche-Comté, Universite Paris Descartes, Université Paris VI Pierre et Marie Curie - Immunity & Cancer, Assistance Publique-Hopitaux de Paris (AP-HP) - Hôpital Européen Georges Pompidou, Université Paris Cité, Université Paris Cité, Clinique Saint Anne, Université Paris Cité and Independent
Downloads 139 (530,816)

Abstract:

Loading...

colorectal cancer, immune score, adenocarcinoma, chemotherapy, immune checkpoint inhibitor

2.

Nal-Iri/Lv5-Fu Versus Paclitaxel as Second-Line Therapy in Patients with Metastatic Esophageal Squamous Cell Carcinoma (Prodige 62-Ffcd 1701-Oesiri)

Number of pages: 29 Posted: 16 Jul 2025
Université de Poitiers - Gastroenterology Department, affiliation not provided to SSRN, Assistance Publique-Hopitaux de Paris (AP-HP) - Hôpital Européen Georges Pompidou, University of Franche-Comté, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Limoges - CHU Limoges, Groupe Hospitalier Diaconesses-Croix St-Simon, Perpignan Hospital Center, affiliation not provided to SSRN, CHU de Reims, CHU Rennes, CHU Rouen, CHRU Tours, INSERM UMR 1231 CADIR and affiliation not provided to SSRN
Downloads 22 (1,436,435)

Abstract:

Loading...

Esophageal cancer, irinotecan, paclitaxel, squamous cell carcinoma

3.

Prediction of chemotherapy free interval (CFI) after induction chemotherapy in metastatic colorectal cancer (mCRC) based on a meta-analysis on ARCAD database: the CFI PREDICT project

Number of pages: 32 Posted: 08 Jul 2026
University of Lorraine - Department of Hepatogastroenterology, University of San Francisco, Fondation ARCAD, University of Franche-Comté, affiliation not provided to SSRN, University College London, Mayo Clinic, Hôpital Franco-Britannique, Utrecht University - University Medical Center (Utrecht), University of Liverpool, Imperial College London - Hammersmith Hospital, Asklepios Tumorzentrum Hamburg, University of Amsterdam - University Medical Center, affiliation not provided to SSRN, Fondation ARCAD, Sorbonne University, Cardiff University - Centre for Trials Research and Université Paris Cité
Downloads 17

Abstract:

Loading...

(MeSH terms): metastatic colorectal cancer, maintenance strategy, prognostic score, shared medical decision